Arbutus Biopharma Corp (ABUS)

3.42 +0.13 (+3.95%) USD  |  NASDAQ  |  Jan 03, 16:00
3.37 -0.05 (-1.46%) After-Hours: 04:38
More

Arbutus Biopharma Research and Development Expense (Annual): 73.70M for Dec. 31, 2023

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for ABUS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Biomarin Pharmaceutical Inc 746.77M
Amicus Therapeutics Inc 152.38M
Ionis Pharmaceuticals Inc 899.62M
GlycoMimetics Inc 20.07M
FibroGen Inc 282.86M